Prevalence of chronic diseases by immigrant status and disparities in chronic

disease management in immigrants: a population-based cohort study, Valore

Project by Buja, Alessandra et al.
Buja et al. BMC Public Health 2013, 13:504
http://www.biomedcentral.com/1471-2458/13/504RESEARCH ARTICLE Open AccessPrevalence of chronic diseases by immigrant
status and disparities in chronic disease
management in immigrants: a population-based
cohort study, Valore Project
Alessandra Buja1*, Rosa Gini2, Modesta Visca3, Gianfranco Damiani4, Bruno Federico5, Paolo Francesconi2,
Daniele Donato6, Alessandro Marini7, Andrea Donatini8, Salvatore Brugaletta9, Vincenzo Baldo1,
Mariadonata Bellentani3 and Valore ProjectAbstract
Background: For chronic conditions, disparities can take effect cumulatively at various times as the disease
progresses, even when care is provided. The aim of this study was to quantify the prevalence of diabetes,
congestive heart failure (CHF) and coronary heart disease (CHD) in adults by citizenship, and to compare the
performance of primary care services in managing these chronic conditions, again by citizenship.
Methods: This is a population-based retrospective cohort study on 1,948,622 people aged 16 years or more
residing in Italy. A multilevel regression model was applied to analyze adherence to care processes using
explanatory variables at both patient and district level.
Results: The age-adjusted prevalence of diabetes was found higher among immigrants from high migratory pressure
countries (HMPC) than among Italians, while the age-adjusted prevalence of CHD and CHF was higher for Italians than
for HMPC immigrants or those from highly-developed countries (HDC). Our results indicate lower levels in all quality
management indicators for citizens from HMPC than for Italians, for all the chronic conditions considered. Patients from
HDC did not differ from Italian in their adherence to disease management schemes.
Conclusion: This study revealed a different prevalence of chronic diseases by citizenship, implying a different burden
of primary care by citizenship. Our findings show that more effort is needed to guarantee migrant-sensitive primary
health care.Background
Access to health care (in the sense of the timely use of
personal health care services to achieve the best health
outcomes) is an essential prerequisite for ensuring good-
quality health care and improving quality of life, and life
expectancy [1]. From the perspectives of European inte-
gration and human rights, the health of migrants and their
access to health care are important health policy issues
[2,3]. Immigration is a phenomenon that has increased
considerably in Italy in the last decade: foreign residents* Correspondence: alessandra.buja@unipd.it
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reproduction in any medium, provided the ornumbered 356,000 in 1991 (0.63% of the population),
while they totaled 1.3 million (2.3%) in 2001, meaning
a fourfold increase in ten years. By 2008, there were
3,432,651 regular immigrants registered in Italy, accounting
for 6.5% of the population [4]. Clear legislation was enacted
as of 1998 to regulate the immigrant population’s access to
services provided under the Italian national health system
(NHS). The declared objective is to allow legal immigrants
access to health services on a par with Italian citizens
[5]. The Italian NHS is funded mainly through taxes
and provides universal access to health services. General
practitioners (GPs) act as gatekeepers to the health system.
Regular immigrants register with the NHS in the same
way as Italian citizens they have access to: primary care,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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care [6]. In recent years, a growing body of literature has
focused on whether there are disparities in how immigrants
and the autochthonous population access the health
services, even though the universality of the health
benefits for virtually everyone in the country is assured.
After controlling for individual characteristics, Giannoni [7]
found that foreigners were less likely to access healthcare
services than Italian citizens. Another report [8] indicated
that foreigners and foreign-born people suffer from unequal
access to health care services; they are more likely to
contact emergency services and less likely to visit specialist
doctors or use preventive care, while no differences
emerged in their use of primary care. More detailed
information is needed to assess migrants’ use of primary
health care services with a view to monitoring and
improving their health, and assuring appropriate and
accessible primary health care services to this portion
of the population [9]. In fact, primary care is the first
interface between individuals, families and communities,
and the NHS, bringing health care as close as possible to
where people live and work, and it is this level of care that
ensures a reducing in health disparities across population
subgroups [10]. Furthermore the need for better data
on migrant health issues has also been recognized in
the World Health Organization (WHO) resolution on
the health of migrants [11].
Worldwide, there is currently a growing interest in
redesigning health care organizations, and primary care
in particular, to improve the quality of care for chronic
diseases (which have overtaken infectious diseases as the
leading cause of death and disability) and to guarantee their
equitable management. In chronic conditions, disparities
can take effect cumulatively at various times as the disease
progresses: in its genesis, or when it is still only latent
(in terms of exposure to risk factors), and after it has
been recognized (in the expression of the demand for), as
well as when care is provided (in the diagnostic treatment
and monitoring process). Such disparities lead to health
inequalities that affect the prevalence of a chronic disease
and its negative outcomes and related mortality rates.
The aim of the present study was: (i) to investigate the
prevalence of certain major chronic diseases, i.e. diabetes,
coronary heart disease (CHD), and congestive heart failure
(CHF), by citizenship; and (ii) to compare Italian and
non-Italian citizens’ adherence to disease management
guidelines, based on the rationale that measuring adherence
could shed light on whether physicians achieve the same
degree of patient involvement in the management of
disease for immigrants as for the Italian population.
Methods
Italy is divided administratively into 20 regions, and
each regional government is responsible for fulfillingthe objectives of the National Health Plan in its area.
These regional authorities plan and organize health
care facilities and activities through their regional
health departments. They also coordinate and control
local health units (LHU), each of which is a separate
NHS unit that plans and delivers health care services
to its local community. Each LHU is organized into
geographical subareas called Health Districts (HD), which
manage all the local primary care structures and commu-
nity services. In Italy, all residents registered with the
NHS (be they Italians or regular immigrants) are listed
with a general practitioner (GP) of their choice. GPs have
a gate-keeping role. Exemptions from prescription charges
for drugs and appropriate diagnostic tests (specific to each
chronic condition) are currently applicable to patients
with certain chronic conditions, as established in a Decree
of the Ministry of Public Health approved in 1999. Such
patients need to exhibit their GP’s prescription to obtain
exempted drugs and diagnostic tests.
Data and variables
Six Italian regions, i.e. two in northern Italy (Lombardy
and Veneto), three in central Italy (Emilia Romagna,
Tuscany and Marche), and one in southern Italy (Sicily)
took part in the VALORE project, a scheme organized
by the National Agency for Regional Health Systems to
assess the association between quality of care for chronic
diseases and the organization of primary care [12]. The
present study was an offshoot of this project, involving
one or two LHUs from each region (8 in all) and 2–4
HDs for each LHU (21 in all), which shared their data;
each regional system chose which LHUs and HDs to
enroll in the study. The dataset used in our analysis
was produced by automatically processing administrative
records. The number of individuals aged 16 years or
more as at 1 January 2008 amounted to 1,948,622; the
cases of diabetes, CHD or CHF were identified by means
of algorithms developed by the Tuscany Regional Public
Health Agency, based on the diagnoses indicated in
the hospital discharge records or on disease-specific
drug-dispensing records, or disease-specific health care
copayment exemptions.
This procedure enabled us to identify 105,987 patients
with diabetes, 86,725 with CHD, and 28,062 with CHF, who
formed the samples of patients considered in this study.
Process indicators, which were used to assess what the
health care provider did for a given patient and how well
it was done [13], were chosen among those identified
and defined by scientific associations as quality measures
for improving patient outcomes.
In particular, for the diabetics we measured three
indicators that the OECD [14] considers indicative of
the quality of care for diabetes at health system level, i.e.:
annual HbA1c testing; annual screening for nephropathy;
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calculated in terms of: the percentage of patients who
had one or more HbA1c test a year; the percentage of
patients who had at least one microalbuminuria test
during the year considered; the percentage of patients
who had at least one annual LDL cholesterol test.
For cases of CHD, we measured three indicators that
the Chronic Stable Coronary Artery Disease Work Group
[15] considers as quality measures of care for CHF for
the purpose of improving outcomes for outpatients with
chronic stable coronary artery disease, i.e.: therapy with
angiotensin-converting enzyme (ACE) inhibitors; therapy
with anti-thrombotic agents; and annual total cholesterol
monitoring. These indicators were calculated in terms
of: the percentage of patients who had at least two
prescriptions of ACE inhibitors in the same year, sepa-
rated by an interval of at least of 180 days; the per-
centage of patients with at least two prescriptions of
anti-thrombotic agents, separated by an interval at
least 180 days; the percentage of patients with at least
one annual total cholesterol test.
For patients with CHF, we chose four indicators that
the Heart Failure Work Group [16] considers indicative of
the quality of care for CHF for the purposes of improving
outcomes for outpatients with heart failure, i.e.: therapy
with ACE inhibitors; therapy with beta-blockers; 6-monthly
monitoring of creatinine, and Na and K; and annual
echocardiography. These indicators were calculated in
terms of: the percentage of patients with at least two
prescriptions of ACE inhibitors in a year, separated by
an interval of at least 180 days; the percentage of patients
with at least two prescriptions of beta-blockers, separated
by an interval of at least 180 days; the percentage of
patients with at least one creatinine, Na and K test in
the previous six months; and the percentage of patients
with at least one annual echocardiogram.
We enrolled people registered with the NHS (all Italian
citizens and regular immigrants), classifying their national-
ity as follows: Italians; immigrants from highly-developed
countries (HDC); and immigrants from high migratory
pressure countries (HMPC) [17]. The HMPC included
new Member States of the European Union, countries in
Central-Eastern Africa, Asia (except for Israel and Japan),
and Central and South America; by extension, stateless
individuals were also included in this group. The HDC
included the other European countries, North America,
Oceania, Israel and Japan.
The Charlson index was calculated to assess patients’
comorbidities. It has been demonstrated that this index
is a valid and reliable method for measuring comorbidity
suitable for use in clinical research and, although it was
developed and validated in hospitalized patients, it has
since been adapted and validated for primary care and
community populations [18].Subjects whose citizenship was not known were excluded
from the analysis (this applied to 5.6% of the diabetics and
CHD patients, and 4.78% of the CHF patients).
Statistical methods
The data were summarized as numbers (percentages) of
subjects for categorical variables. A multilevel logistic
regression model was applied to analyze the association
between nationality and adherence to standards of care.
The data had a hierarchical structure, with the patient as
the first level and the HD as the second level. The
dependent variables were analyzed in dichotomous form
(yes/no) for each patient’s adherence to evidence-based
quality of care requirements for managing the diseases con-
sidered. Besides nationality, the independent variables were:
gender, age band (16–44, 45–64, 65–74, 75–84, >85 years),
time since diagnosis (dichotomized as ≤3 y and >3 y), and
the Charlson index on the first level of the hierarchical
structure, and HD on the second level.
The study complies with the Helsinki Declaration and
with Italian privacy law (Decree No. 196/2003). In addition,
resolution n. 85/2012 of the Italian Guarantor for the
protection of personal data recently confirmed permission
to process personal data for medical, biomedical and
epidemiological research; data concerning health status
can be used in aggregated form for the purpose of scientific
studies [19]. No identifiable personal details were used
for this study. The dataset used in the study is not available
to the public. Approval for the use of encrypted and
aggregated data was also obtained from the Italian College
of General Practitioners.
Results
The estimated overall crude prevalence of diabetes was
5.43% (95% CI 5.33-5.54); the age-standardized prevalence
amounted to 5.45% (95% CI 5.42 -5.48) among Italian
citizens, 3.83% (95% CI 3.80-3.86) among immigrants
from HDC, and 6.96% (95% CI 6.93-7.00) among HMPC
immigrants.
The estimated overall crude prevalence of CHD was
4.20% (95% CI 4.17-4.23); the age-standardized prevalence
amounted to 4.52% (95% CI 4.49-4.55), 3.05% (95% CI
3.03-3.08) and 3.78% (95% CI 3.75-3.81), respectively, for
the Italian, HDC and HMPC citizens.
The estimated overall crude prevalence of CHF was 1.44%
(95% CI 1.42 -1.46), with an age-standardized prevalence
of 1.48% (95% CI 1.46-1.49), 1.12% (95% CI 1.10-1.13) and
1.19% (95% CI 1.17-1.20), respectively, in the Italian, HDC
and HMPC groups.
Considering the diabetics as a whole, HbA1c tests had
been conducted in 60.50% of cases, LDL cholesterol tests
in 57.50%, and creatinine in 63.27%, while only 44.19%
of the diabetic patients had undergone a comprehensive
assessment including all three blood tests. Overall, 57.35%
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hibitors and 61.91% with antithrombotic therapy; LDL
cholesterol tests were performed in 54.01%. As for the
CHF patients, 55.46% were treated with ACE inhibitors and
36.73% with beta-blockers; 56.45% were tested for Na
and K, and only 15.45% had undergone echocardiography.
The results of our multilevel logistic regressions (Tables 1,
2, 3) showed marked differences in all quality management
indicators for the three chronic diseases considered. By
comparison with their Italian counterparts, people from
HMPC with diabetes had more than 30% lower odds of
annual glycated hemoglobin testing, 29% lower odds of
annual renal function tests, and 45% lower odds of having
their cholesterol profile checked, whereas diabetics from
HDC did not differ from Italian diabetics in terms of their
adherence to disease management schemes. Patients from
HMPC with CHD had a more than 40% lower odds of
being treated with ACE inhibitors and anti-thrombotic
agents, and were only half as likely as Italians to have
their cholesterol profile checked. Here again, CHD
patients from HDC did not differ from native Italians
in their adherence to disease management schemes
(apart from the use of ACE inhibitor therapy). CHF
patients from HMPC had almost 70% lower odds of being
treated with ACE inhibitors, 50% lower odds when it came
to beta-blockers, a ≈ 40% lower odds of having their
creatinine, Na and K checked, and ≈ 30% lower odds of
undergoing echocardiography, while CHF patients from
HDC did not differ from Italian citizens in their adherence
to disease management programs.
Discussion
To the best of our knowledge, this is the first study to
be conducted in Europe on equity in access to health
care services for the management of chronic diseases, by
migrant status. An earlier article [20] claimed that the
EU countries have a relatively weak system for assessing
the needs and planning the health care of their migrant
and ethnic minority populations. The lack of relevantTable 1 Multilevel logistic regressions in diabetics (dependent va
Annual HbA1c testing
Nationality (Italian = reference) HDC
HMPC
Annual screening for nephropathy
Nationality (Italian = reference) HDC
HMPC
Annual LDL cholesterol testing
Nationality (Italian = reference) HDC
HMPC
All regressions adjusted for gender, age band (16–44, 45–64, 65–74, 75–84, > 85 ye
index on a first level, and health districts on a second level.data on cardiovascular diseases (CVD) and diabetes across
the EU needs to be urgently addressed. Our findings show
that the age-standardized prevalence of CHD and CHF is
significantly lower in immigrants than in Italian citizens,
probably due to a ‘healthy immigrant effect’. But the
age-standardized prevalence of diabetes is significantly
higher among HMPC immigrants than for Italian citizens,
probably due to ethnic differences in the prevalence of this
disease, as previously documented in the literature [21,22].
Our study found inequalities in diabetes management
by citizenship, and particularly that diabetic patients
from HMPC were far less likely than Italian patients to
score well in all three indicators of the quality of their
disease’s management. An Irish study [23] on disparities
in the management of diabetics by immigrant status also
showed that immigrants had a worse glycemic control
and were less likely to monitor their blood sugar levels
daily. A number of American studies [24,25] identified
mainly racial disparities and ethnic differences in the
quality of diabetes care, but the immigration phenomena
and health care system in the US differ considerably
from those of the EU: the US population includes many
longstanding immigrants and research has focused more
on inequalities by ethnic minority group rather than by
migrant status.
As for the disparities in the management of immigrants
with cardiovascular diseases, one study found immigrants
more likely than patients born in the US to be unaware of
their CVD risk factors, and consequently less motivated
to seek treatment or modify their behavior to prevent
negative CVD outcomes [26]. This is consistent with
our finding that immigrants from HMPC with CHD or
CHF fared less well in all management indicators and
were up to 70% less likely to be taking ACE inhibitors
than their Italian counterparts.
Migrants may experience language difficulties, issues
concerning their cultural beliefs, and problems with
obtaining transportation, time off work, and child care.
They may also be less attentive to their health, as wellriable: adherence to disease management quality indicators)
OR 95% LL 95% UL p
0.95 0.75 1.21 0.69
0.64 0.59 0.69 0.00
1.02 0.80 1.30 0.90
0.71 0.66 0.77 0.00
0.95 0.75 1.20 0.67
0.55 0.50 0.60 0.00
ars), time since diagnosis (dichotomized as ≤3y and >3y), and the Charlson
Table 2 Multilevel logistic regressions in CHD patients (dependent variable: adherence to disease management
quality indicators)
OR 95% LL 95% UL p
Therapy with ACE inhibitors
Nationality (Italian = reference) HDC 0.73 0.55 0.97 0.03
HMPC 0.58 0.50 0.67 0.00
Therapy with anti-thrombotic agents
Nationality (Italian = reference) HDC 1.02 0.76 1.39 0.86
HMPC 0.59 0.50 0.68 0.00
Annual total cholesterol monitoring
Nationality (Italian = reference) HDC 0.84 0.63 1.12 0.23
HMPC 0.47 0.40 0.54 0.00
All regressions adjusted for gender, age band (16–44, 45–64, 65–74, 75–84, > 85 years), time since diagnosis (dichotomized as ≤3y and >3y), and the Charlson
index on a first level, and health districts on a second level.
Buja et al. BMC Public Health 2013, 13:504 Page 5 of 7
http://www.biomedcentral.com/1471-2458/13/504as experiencing cultural barriers to health care (there
are no financial barriers in Italy because chronically ill
patients are exempted from charges for routine tests).
All of these aspects might interfere with how well their
chronic diseases are managed. Newly-arrived migrants
may also be unfamiliar with how the health care system
works in their new place of residence. Access to health
services and their appropriate use are often influenced
by people’s unfamiliarity with enrolment processes and
entry points, and structural barriers to receiving care, and
discouraging or discriminatory treatment by health care
staff. Even when migrants do access health services, they
may find it difficult to explain their symptoms or under-
stand instructions they receive for their treatment [27].
Judging from our findings, action is needed to reduce
disparities, targeting strategies for the immigrant popula-
tion. Until now, a “waiting paradigm” has been adopted in
the Italian approach to primary care, which means waitingTable 3 Multilevel logistic regressions in CHF patients (depe
quality indicators)
O
Therapy with ACE inhibitors
Nationality (Italian = reference) HDC 1.
HMPC 0.
Therapy with beta-blockers
Nationality (Italian = reference) HDC 0.
HMPC 0.
Creatinine, Na and K monitoring
Nationality (Italian = reference) HDC 1.
HMPC 0.
Annual echocardiogram
Nationality (Italian = reference) HDC 1.
HMPC 0.
All regressions adjusted for gender, age band (16–44, 45–64, 65–74, 75–84, > 85 ye
index on a first level, and health districts on a second level.for an event to take action on, a problem to solve. Waiting
is the classical health care paradigm of the biomedical
model, and it has also become the dominant paradigm in
territorial and primary care [28]. One way to reduce the
inequalities identified in the management of chronic
conditions would be to adopt a more proactive approach
to primary care, seeking to identify patients’ needs without
waiting for them to come forward. A model tending to
provide a proactive care is particularly important when it
comes to managing chronic diseases, and part of the
empowerment philosophy includes interactive teaching
strategies designed to involve patients in solving their
problems, addressing their cultural and social needs,
making them take some responsibility for their daily
care, and encouraging them to monitor their risk factors
and complications regularly [29]. Such a model had never
been applied in Italy up until the time to which the data
analyzed in the present study refer; more recently, it hasndent variable:adherence to disease management
R 95% LL 95% UL p
37 0.80 2.32 0.25
34 0.26 0.45 0.00
87 0.52 1.45 0.59
50 0.37 0.66 0.00
04 0.64 1.70 0.87
57 0.44 0.76 0.00
01 0.55 1.86 0.96
68 0.48 0.97 0.03
ars), time since diagnosis (dichotomized as ≤3y and >3y), and the Charlson
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useful to assess whether it can reduce chronic disease
management inequalities by citizenship.
Several other aspects could be addressed to improve
migrants’ access to quality health care [30], e.g. extending
the hours when the services are provided, the case
management of patients with chronic diseases [31]. One
review [32] designed to identify the action taken by health
systems to improve care for diabetes among the socially
disadvantaged found that cultural tailoring of intervention,
community educators, one-on-one interventions with
customized assessments and reassessments, and high-
intensity interventions (>10 contact times) delivered over
a lengthy period of time improved diabetes care among
socially disadvantaged populations.
Our study has some limitations. First of all, not all the
relevant socio-economic factors (e.g. level of formal
education) were available in the database. In addition, only
care process measures were assessed, and it is debatable
whether better care processes are genuinely linked to an
improvement in intermediate or final outcomes for patients
[33,34]. On the other hand, a recent study on diabetics [35]
found that those receiving the worst quality of care, as
measured by process quality-of-care indicators based on
screening guidelines, were at higher risk of all-cause
mortality and cardiovascular morbidity than patients
receiving the highest process quality of care. The strength
of our study lies in that it was conducted on an unrestricted
and unselected population of primary care patients, thus
enabling an estimation of the prevalence of the diseases of
interest and of the related primary care performance
measures. On the other hand, these data could be biased
due to an opportunistic sample of LHUs being enrolled
by the regional systems. This important methodological
issue was addressed by a recent paper on the consistency of
the Valore database [12] used in the present study vis-à-vis
other sources of data, such as primary care medical records
and national surveys: the prevalence estimates of ischemic
heart disease and treated diabetes were consistent across
the regions between the Valore database and clinical pri-
mary care databases; for heart failure, the Valore estimates
were systematically higher than GPs’ estimates in all five
regions considered, the highest difference being 1.4% vs
1.1%. Finally, some subjects involved in the present study
were lost to follow-up, as is usually the case in cohort stud-
ies. Drop-out from the cohort was recorded for around 4%
of diabetics (and slightly more for non-Italian patients), and
for around 6% and 10% of patients with CHD and CHF, re-
spectively (with lower percentages for non-Italian patients).
This happened when patients either died or moved away
during the one-year follow-up. Loss to follow-up therefore
should not have affected the direction of the disparity
identified, but it has to be said that non-Italian patients
might decide to leave the area without informing the LHU(we are unable to quantify the effect of this, but it is
unlikely to be able to justify the differences we measured).Conclusion
In conclusion, our study shows that management indicators
are useful not only for the overall evaluation of the care
process for a given disease, but also to monitor disparities
in the provision of health care services. Based on such
indicators, the present study revealed numerous oppor-
tunities for improving the health care and management
of immigrants from high migratory pressure countries.
Our findings disclose citizenship-related inequalities in
the provision of primary care for the chronic diseases
investigated (diabetes, CHD and CHF). It was particularly
evident that diabetic and cardiopathic patients from HMPC
were far less likely than Italian patients to score well in
all indicators of the quality of their disease’s management.
This means that more effort is needed to guarantee
migrant-sensitive primary health care systems.
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